Hans T. Schambye
Chief Executive Officer at Damora Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Damora Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Damora Therapeutics Inc. June 14, 202399.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Damora Therapeutics Inc. | Option exercise | +1,360 | — | — |
| Jan 2, 2026 | Damora Therapeutics Inc. | Open-market sale | −700 | $21.38 | $14,966 |
| Jul 3, 2025 | Damora Therapeutics Inc. | Option exercise | +1,360 | — | — |
| Jul 3, 2025 | Damora Therapeutics Inc. | Open-market sale | −735 | $3.38 | $2,484 |
| Jan 3, 2025 | Damora Therapeutics Inc. | Option exercise | +2,640 | — | — |
| Jan 3, 2025 | Damora Therapeutics Inc. | Open-market sale | −1,341 | $5.60 | $7,510 |
Questions about Hans T. Schambye
What boards is Hans T. Schambye on?
Hans T. Schambye sits on the board of Damora Therapeutics Inc.
What company is Hans T. Schambye the CEO of?
Hans T. Schambye is Chief Executive Officer of Damora Therapeutics Inc.
How long has Hans T. Schambye served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.